nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—Bifonazole—Letrozole—breast cancer	0.144	0.372	CrCrCtD
Modafinil—CYP3A4—breast cancer	0.0878	1	CbGaD
Modafinil—CYP2B6—Thiotepa—breast cancer	0.0254	0.0752	CbGbCtD
Modafinil—Phenoxybenzamine—Toremifene—breast cancer	0.0252	0.065	CrCrCtD
Modafinil—Dextropropoxyphene—Toremifene—breast cancer	0.0252	0.065	CrCrCtD
Modafinil—CYP1A2—Anastrozole—breast cancer	0.0196	0.0582	CbGbCtD
Modafinil—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0192	0.0497	CrCrCtD
Modafinil—Methadyl Acetate—Tamoxifen—breast cancer	0.0192	0.0497	CrCrCtD
Modafinil—CYP1A2—Toremifene—breast cancer	0.0179	0.0532	CbGbCtD
Modafinil—CYP2C9—Anastrozole—breast cancer	0.0177	0.0524	CbGbCtD
Modafinil—Orphenadrine—Toremifene—breast cancer	0.0176	0.0455	CrCrCtD
Modafinil—Benzphetamine—Toremifene—breast cancer	0.0176	0.0455	CrCrCtD
Modafinil—CYP3A5—Lapatinib—breast cancer	0.0176	0.0521	CbGbCtD
Modafinil—CYP2B6—Raloxifene—breast cancer	0.0169	0.0502	CbGbCtD
Modafinil—Benzyl Benzoate—Toremifene—breast cancer	0.0163	0.0422	CrCrCtD
Modafinil—Phenoxybenzamine—Tamoxifen—breast cancer	0.0158	0.0408	CrCrCtD
Modafinil—Dextropropoxyphene—Tamoxifen—breast cancer	0.0158	0.0408	CrCrCtD
Modafinil—Diphenhydramine—Toremifene—breast cancer	0.0156	0.0404	CrCrCtD
Modafinil—CYP2C19—Lapatinib—breast cancer	0.0142	0.0421	CbGbCtD
Modafinil—CYP3A4—Exemestane—breast cancer	0.0136	0.0402	CbGbCtD
Modafinil—CYP2C9—Idarubicin—breast cancer	0.0134	0.0397	CbGbCtD
Modafinil—Methadone—Tamoxifen—breast cancer	0.0132	0.0342	CrCrCtD
Modafinil—CYP3A4—Letrozole—breast cancer	0.0115	0.0342	CbGbCtD
Modafinil—CYP2B6—Tamoxifen—breast cancer	0.0112	0.0331	CbGbCtD
Modafinil—Benzphetamine—Tamoxifen—breast cancer	0.0111	0.0286	CrCrCtD
Modafinil—Orphenadrine—Tamoxifen—breast cancer	0.0111	0.0286	CrCrCtD
Modafinil—CYP3A4—Anastrozole—breast cancer	0.0103	0.0305	CbGbCtD
Modafinil—Benzyl Benzoate—Tamoxifen—breast cancer	0.0102	0.0265	CrCrCtD
Modafinil—Diphenhydramine—Tamoxifen—breast cancer	0.00981	0.0254	CrCrCtD
Modafinil—CYP3A4—Toremifene—breast cancer	0.0094	0.0279	CbGbCtD
Modafinil—CYP3A5—Tamoxifen—breast cancer	0.00881	0.0261	CbGbCtD
Modafinil—CYP3A4—Fulvestrant—breast cancer	0.00874	0.0259	CbGbCtD
Modafinil—CYP2B6—Irinotecan—breast cancer	0.00858	0.0254	CbGbCtD
Modafinil—CYP3A4—Thiotepa—breast cancer	0.00779	0.0231	CbGbCtD
Modafinil—CYP2C9—Capecitabine—breast cancer	0.00734	0.0218	CbGbCtD
Modafinil—CYP3A4—Ixabepilone—breast cancer	0.00712	0.0211	CbGbCtD
Modafinil—CYP2C19—Tamoxifen—breast cancer	0.0071	0.0211	CbGbCtD
Modafinil—CYP3A4—Lapatinib—breast cancer	0.00686	0.0203	CbGbCtD
Modafinil—CYP3A5—Paclitaxel—breast cancer	0.00685	0.0203	CbGbCtD
Modafinil—CYP3A5—Irinotecan—breast cancer	0.00676	0.02	CbGbCtD
Modafinil—CYP1A2—Tamoxifen—breast cancer	0.00655	0.0194	CbGbCtD
Modafinil—CYP2C9—Tamoxifen—breast cancer	0.00591	0.0175	CbGbCtD
Modafinil—CYP3A4—Raloxifene—breast cancer	0.0052	0.0154	CbGbCtD
Modafinil—CYP3A5—Docetaxel—breast cancer	0.00496	0.0147	CbGbCtD
Modafinil—CYP1A2—Fluorouracil—breast cancer	0.00483	0.0143	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—breast cancer	0.00469	0.0139	CbGbCtD
Modafinil—CYP2C9—Paclitaxel—breast cancer	0.0046	0.0136	CbGbCtD
Modafinil—CYP2C9—Fluorouracil—breast cancer	0.00435	0.0129	CbGbCtD
Modafinil—CYP3A4—Vinorelbine—breast cancer	0.0038	0.0113	CbGbCtD
Modafinil—CYP3A4—Tamoxifen—breast cancer	0.00343	0.0102	CbGbCtD
Modafinil—CYP3A4—Mitoxantrone—breast cancer	0.00335	0.00993	CbGbCtD
Modafinil—CYP3A4—Paclitaxel—breast cancer	0.00267	0.00792	CbGbCtD
Modafinil—CYP3A4—Irinotecan—breast cancer	0.00264	0.00782	CbGbCtD
Modafinil—CYP3A4—Vinblastine—breast cancer	0.00234	0.00695	CbGbCtD
Modafinil—CYP3A4—Docetaxel—breast cancer	0.00193	0.00573	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—breast cancer	0.00144	0.00427	CbGbCtD
Modafinil—Bifonazole—CYP17A1—breast cancer	0.000202	0.0791	CrCbGaD
Modafinil—Nepafenac—PTGS1—breast cancer	0.000126	0.0494	CrCbGaD
Modafinil—Oxaprozin—PTGS1—breast cancer	0.000105	0.0411	CrCbGaD
Modafinil—Bifonazole—CYP19A1—breast cancer	0.000103	0.0402	CrCbGaD
Modafinil—Ketoprofen—CXCL8—breast cancer	0.0001	0.0393	CrCbGaD
Modafinil—Fenoprofen—PTGS1—breast cancer	8.66e-05	0.034	CrCbGaD
Modafinil—Orphenadrine—SCN10A—breast cancer	7.9e-05	0.031	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP19A1—breast cancer	7.72e-05	0.0303	CrCbGaD
Modafinil—Nepafenac—PTGS2—breast cancer	7.21e-05	0.0283	CrCbGaD
Modafinil—Phenylbutazone—PTGS1—breast cancer	6.93e-05	0.0272	CrCbGaD
Modafinil—Fosphenytoin—CYP3A4—breast cancer	6.36e-05	0.0249	CrCbGaD
Modafinil—Warfarin—CYP1A1—breast cancer	6.06e-05	0.0238	CrCbGaD
Modafinil—Oxaprozin—PTGS2—breast cancer	5.99e-05	0.0235	CrCbGaD
Modafinil—Fosphenytoin—ALB—breast cancer	5.55e-05	0.0218	CrCbGaD
Modafinil—Ketoprofen—PTGS1—breast cancer	5.11e-05	0.02	CrCbGaD
Modafinil—Benzatropine—CYP2D6—breast cancer	4.99e-05	0.0196	CrCbGaD
Modafinil—Fenoprofen—PTGS2—breast cancer	4.95e-05	0.0194	CrCbGaD
Modafinil—Bifonazole—CYP3A4—breast cancer	4.82e-05	0.0189	CrCbGaD
Modafinil—Cinnarizine—CYP1A1—breast cancer	4.8e-05	0.0188	CrCbGaD
Modafinil—Methadone—CYP19A1—breast cancer	4.53e-05	0.0177	CrCbGaD
Modafinil—Fenoprofen—ALB—breast cancer	4.41e-05	0.0173	CrCbGaD
Modafinil—Phenprocoumon—CYP3A4—breast cancer	4.36e-05	0.0171	CrCbGaD
Modafinil—Oxcarbazepine—CYP3A4—breast cancer	4.24e-05	0.0166	CrCbGaD
Modafinil—Phenylbutazone—CYP3A4—breast cancer	4.05e-05	0.0159	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—breast cancer	3.96e-05	0.0155	CrCbGaD
Modafinil—Warfarin—CYP3A4—breast cancer	3.87e-05	0.0152	CrCbGaD
Modafinil—Phenprocoumon—ALB—breast cancer	3.81e-05	0.0149	CrCbGaD
Modafinil—Diphenhydramine—PTGS1—breast cancer	3.77e-05	0.0148	CrCbGaD
Modafinil—Oxcarbazepine—ALB—breast cancer	3.7e-05	0.0145	CrCbGaD
Modafinil—Dextropropoxyphene—CYP2D6—breast cancer	3.65e-05	0.0143	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP3A4—breast cancer	3.63e-05	0.0142	CrCbGaD
Modafinil—Cinnarizine—CYP2D6—breast cancer	3.58e-05	0.014	CrCbGaD
Modafinil—Warfarin—ALB—breast cancer	3.38e-05	0.0132	CrCbGaD
Modafinil—Atomoxetine—CYP2D6—breast cancer	3.18e-05	0.0125	CrCbGaD
Modafinil—Dextropropoxyphene—CYP3A4—breast cancer	3.13e-05	0.0123	CrCbGaD
Modafinil—Fentanyl—CYP3A4—breast cancer	3.1e-05	0.0121	CrCbGaD
Modafinil—Ketoprofen—PTGS2—breast cancer	2.92e-05	0.0115	CrCbGaD
Modafinil—Carbamazepine—CYP3A4—breast cancer	2.89e-05	0.0113	CrCbGaD
Modafinil—Phenytoin—CYP3A4—breast cancer	2.81e-05	0.011	CrCbGaD
Modafinil—Benzphetamine—CYP3A4—breast cancer	2.75e-05	0.0108	CrCbGaD
Modafinil—Atomoxetine—CYP3A4—breast cancer	2.73e-05	0.0107	CrCbGaD
Modafinil—Phenoxybenzamine—CYP3A4—breast cancer	2.63e-05	0.0103	CrCbGaD
Modafinil—Ketoprofen—ALB—breast cancer	2.6e-05	0.0102	CrCbGaD
Modafinil—Fentanyl—ABCB1—breast cancer	2.58e-05	0.0101	CrCbGaD
Modafinil—Diphenhydramine—CYP2D6—breast cancer	2.57e-05	0.0101	CrCbGaD
Modafinil—Methadone—CYP2D6—breast cancer	2.48e-05	0.00971	CrCbGaD
Modafinil—Phenytoin—ALB—breast cancer	2.45e-05	0.00961	CrCbGaD
Modafinil—Insomnia—Capecitabine—breast cancer	2.43e-05	0.000182	CcSEcCtD
Modafinil—Rash—Fluorouracil—breast cancer	2.42e-05	0.000182	CcSEcCtD
Modafinil—Dermatitis—Fluorouracil—breast cancer	2.42e-05	0.000181	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—breast cancer	2.41e-05	0.000181	CcSEcCtD
Modafinil—Paraesthesia—Capecitabine—breast cancer	2.41e-05	0.000181	CcSEcCtD
Modafinil—Carbamazepine—ABCB1—breast cancer	2.41e-05	0.00944	CrCbGaD
Modafinil—Decreased appetite—Docetaxel—breast cancer	2.41e-05	0.000181	CcSEcCtD
Modafinil—Hypersensitivity—Paclitaxel—breast cancer	2.41e-05	0.000181	CcSEcCtD
Modafinil—Headache—Fluorouracil—breast cancer	2.4e-05	0.00018	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—breast cancer	2.4e-05	0.00018	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—breast cancer	2.4e-05	0.00018	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—breast cancer	2.4e-05	0.00018	CcSEcCtD
Modafinil—Gastrointestinal disorder—Docetaxel—breast cancer	2.39e-05	0.000179	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—breast cancer	2.39e-05	0.000179	CcSEcCtD
Modafinil—Dyspnoea—Capecitabine—breast cancer	2.39e-05	0.000179	CcSEcCtD
Modafinil—Fatigue—Docetaxel—breast cancer	2.39e-05	0.000179	CcSEcCtD
Modafinil—Angiopathy—Epirubicin—breast cancer	2.39e-05	0.000179	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—breast cancer	2.38e-05	0.000179	CcSEcCtD
Modafinil—Nausea—Irinotecan—breast cancer	2.38e-05	0.000179	CcSEcCtD
Modafinil—Nausea—Mitoxantrone—breast cancer	2.38e-05	0.000179	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—breast cancer	2.37e-05	0.000178	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—breast cancer	2.37e-05	0.000178	CcSEcCtD
Modafinil—Constipation—Docetaxel—breast cancer	2.37e-05	0.000178	CcSEcCtD
Modafinil—Pain—Docetaxel—breast cancer	2.37e-05	0.000178	CcSEcCtD
Modafinil—Back pain—Methotrexate—breast cancer	2.37e-05	0.000178	CcSEcCtD
Modafinil—Dyspepsia—Capecitabine—breast cancer	2.36e-05	0.000177	CcSEcCtD
Modafinil—Chills—Epirubicin—breast cancer	2.36e-05	0.000177	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—breast cancer	2.35e-05	0.000176	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—breast cancer	2.34e-05	0.000176	CcSEcCtD
Modafinil—Asthenia—Paclitaxel—breast cancer	2.34e-05	0.000176	CcSEcCtD
Modafinil—Phenytoin—ABCB1—breast cancer	2.34e-05	0.00917	CrCbGaD
Modafinil—Decreased appetite—Capecitabine—breast cancer	2.33e-05	0.000175	CcSEcCtD
Modafinil—Nausea—Gemcitabine—breast cancer	2.32e-05	0.000174	CcSEcCtD
Modafinil—Gastrointestinal disorder—Capecitabine—breast cancer	2.31e-05	0.000174	CcSEcCtD
Modafinil—Fatigue—Capecitabine—breast cancer	2.31e-05	0.000174	CcSEcCtD
Modafinil—Pruritus—Paclitaxel—breast cancer	2.31e-05	0.000174	CcSEcCtD
Modafinil—Mental disorder—Epirubicin—breast cancer	2.3e-05	0.000173	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—breast cancer	2.3e-05	0.000173	CcSEcCtD
Modafinil—Pain—Capecitabine—breast cancer	2.29e-05	0.000172	CcSEcCtD
Modafinil—Constipation—Capecitabine—breast cancer	2.29e-05	0.000172	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—breast cancer	2.29e-05	0.000172	CcSEcCtD
Modafinil—Feeling abnormal—Docetaxel—breast cancer	2.28e-05	0.000171	CcSEcCtD
Modafinil—Nausea—Fluorouracil—breast cancer	2.28e-05	0.000171	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—breast cancer	2.27e-05	0.00017	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—breast cancer	2.26e-05	0.00017	CcSEcCtD
Modafinil—Anaemia—Methotrexate—breast cancer	2.26e-05	0.00017	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—breast cancer	2.26e-05	0.000169	CcSEcCtD
Modafinil—Flatulence—Epirubicin—breast cancer	2.26e-05	0.000169	CcSEcCtD
Modafinil—Tension—Epirubicin—breast cancer	2.25e-05	0.000169	CcSEcCtD
Modafinil—Dysgeusia—Epirubicin—breast cancer	2.24e-05	0.000168	CcSEcCtD
Modafinil—Diarrhoea—Paclitaxel—breast cancer	2.24e-05	0.000168	CcSEcCtD
Modafinil—Nervousness—Epirubicin—breast cancer	2.22e-05	0.000167	CcSEcCtD
Modafinil—Back pain—Epirubicin—breast cancer	2.21e-05	0.000166	CcSEcCtD
Modafinil—Feeling abnormal—Capecitabine—breast cancer	2.21e-05	0.000166	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—breast cancer	2.21e-05	0.000166	CcSEcCtD
Modafinil—Malaise—Methotrexate—breast cancer	2.21e-05	0.000166	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—breast cancer	2.2e-05	0.000165	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—breast cancer	2.2e-05	0.000165	CcSEcCtD
Modafinil—Vertigo—Methotrexate—breast cancer	2.2e-05	0.000165	CcSEcCtD
Modafinil—Gastrointestinal pain—Capecitabine—breast cancer	2.19e-05	0.000165	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—breast cancer	2.19e-05	0.000165	CcSEcCtD
Modafinil—Abdominal pain—Docetaxel—breast cancer	2.19e-05	0.000164	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—breast cancer	2.19e-05	0.000164	CcSEcCtD
Modafinil—Chills—Doxorubicin—breast cancer	2.18e-05	0.000164	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—breast cancer	2.17e-05	0.000163	CcSEcCtD
Modafinil—Dizziness—Paclitaxel—breast cancer	2.16e-05	0.000162	CcSEcCtD
Modafinil—Cough—Methotrexate—breast cancer	2.13e-05	0.00016	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—breast cancer	2.13e-05	0.00016	CcSEcCtD
Modafinil—Urticaria—Capecitabine—breast cancer	2.13e-05	0.00016	CcSEcCtD
Modafinil—Methadone—CYP3A4—breast cancer	2.13e-05	0.00833	CrCbGaD
Modafinil—Ill-defined disorder—Epirubicin—breast cancer	2.12e-05	0.000159	CcSEcCtD
Modafinil—Abdominal pain—Capecitabine—breast cancer	2.12e-05	0.000159	CcSEcCtD
Modafinil—Body temperature increased—Capecitabine—breast cancer	2.12e-05	0.000159	CcSEcCtD
Modafinil—Convulsion—Methotrexate—breast cancer	2.12e-05	0.000159	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—breast cancer	2.12e-05	0.000159	CcSEcCtD
Modafinil—Anaemia—Epirubicin—breast cancer	2.12e-05	0.000159	CcSEcCtD
Modafinil—Agitation—Epirubicin—breast cancer	2.1e-05	0.000158	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—breast cancer	2.09e-05	0.000157	CcSEcCtD
Modafinil—Orphenadrine—CYP3A4—breast cancer	2.08e-05	0.00816	CrCbGaD
Modafinil—Chest pain—Methotrexate—breast cancer	2.08e-05	0.000156	CcSEcCtD
Modafinil—Myalgia—Methotrexate—breast cancer	2.08e-05	0.000156	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—breast cancer	2.08e-05	0.000156	CcSEcCtD
Modafinil—Tension—Doxorubicin—breast cancer	2.08e-05	0.000156	CcSEcCtD
Modafinil—Vomiting—Paclitaxel—breast cancer	2.08e-05	0.000156	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—breast cancer	2.07e-05	0.000156	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.07e-05	0.000155	CcSEcCtD
Modafinil—Malaise—Epirubicin—breast cancer	2.06e-05	0.000155	CcSEcCtD
Modafinil—Rash—Paclitaxel—breast cancer	2.06e-05	0.000155	CcSEcCtD
Modafinil—Dermatitis—Paclitaxel—breast cancer	2.06e-05	0.000155	CcSEcCtD
Modafinil—Discomfort—Methotrexate—breast cancer	2.06e-05	0.000154	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—breast cancer	2.06e-05	0.000154	CcSEcCtD
Modafinil—Vertigo—Epirubicin—breast cancer	2.06e-05	0.000154	CcSEcCtD
Modafinil—Syncope—Epirubicin—breast cancer	2.05e-05	0.000154	CcSEcCtD
Modafinil—Back pain—Doxorubicin—breast cancer	2.05e-05	0.000154	CcSEcCtD
Modafinil—Headache—Paclitaxel—breast cancer	2.05e-05	0.000154	CcSEcCtD
Modafinil—Hypersensitivity—Docetaxel—breast cancer	2.04e-05	0.000153	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—breast cancer	2.04e-05	0.000153	CcSEcCtD
Modafinil—Palpitations—Epirubicin—breast cancer	2.02e-05	0.000152	CcSEcCtD
Modafinil—Confusional state—Methotrexate—breast cancer	2.01e-05	0.000151	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—breast cancer	2.01e-05	0.000151	CcSEcCtD
Modafinil—Cough—Epirubicin—breast cancer	2e-05	0.00015	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—breast cancer	2e-05	0.00015	CcSEcCtD
Modafinil—Asthenia—Docetaxel—breast cancer	1.99e-05	0.000149	CcSEcCtD
Modafinil—Convulsion—Epirubicin—breast cancer	1.98e-05	0.000149	CcSEcCtD
Modafinil—Infection—Methotrexate—breast cancer	1.98e-05	0.000149	CcSEcCtD
Modafinil—Hypertension—Epirubicin—breast cancer	1.98e-05	0.000148	CcSEcCtD
Modafinil—Hypersensitivity—Capecitabine—breast cancer	1.98e-05	0.000148	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—breast cancer	1.96e-05	0.000148	CcSEcCtD
Modafinil—Pruritus—Docetaxel—breast cancer	1.96e-05	0.000147	CcSEcCtD
Modafinil—Nervous system disorder—Methotrexate—breast cancer	1.96e-05	0.000147	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—breast cancer	1.96e-05	0.000147	CcSEcCtD
Modafinil—Chest pain—Epirubicin—breast cancer	1.95e-05	0.000146	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—breast cancer	1.95e-05	0.000146	CcSEcCtD
Modafinil—Myalgia—Epirubicin—breast cancer	1.95e-05	0.000146	CcSEcCtD
Modafinil—Agitation—Doxorubicin—breast cancer	1.95e-05	0.000146	CcSEcCtD
Modafinil—Anxiety—Epirubicin—breast cancer	1.94e-05	0.000146	CcSEcCtD
Modafinil—Nausea—Paclitaxel—breast cancer	1.94e-05	0.000146	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—breast cancer	1.94e-05	0.000146	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.94e-05	0.000145	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—breast cancer	1.93e-05	0.000145	CcSEcCtD
Modafinil—Discomfort—Epirubicin—breast cancer	1.93e-05	0.000145	CcSEcCtD
Modafinil—Asthenia—Capecitabine—breast cancer	1.92e-05	0.000144	CcSEcCtD
Modafinil—Malaise—Doxorubicin—breast cancer	1.91e-05	0.000143	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—breast cancer	1.91e-05	0.000143	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—breast cancer	1.9e-05	0.000143	CcSEcCtD
Modafinil—Anorexia—Methotrexate—breast cancer	1.9e-05	0.000143	CcSEcCtD
Modafinil—Syncope—Doxorubicin—breast cancer	1.9e-05	0.000143	CcSEcCtD
Modafinil—Pruritus—Capecitabine—breast cancer	1.9e-05	0.000142	CcSEcCtD
Modafinil—Diarrhoea—Docetaxel—breast cancer	1.89e-05	0.000142	CcSEcCtD
Modafinil—Confusional state—Epirubicin—breast cancer	1.88e-05	0.000141	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—breast cancer	1.87e-05	0.00014	CcSEcCtD
Modafinil—Oedema—Epirubicin—breast cancer	1.87e-05	0.00014	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—breast cancer	1.87e-05	0.00014	CcSEcCtD
Modafinil—Hypotension—Methotrexate—breast cancer	1.87e-05	0.00014	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—breast cancer	1.86e-05	0.00014	CcSEcCtD
Modafinil—Infection—Epirubicin—breast cancer	1.86e-05	0.000139	CcSEcCtD
Modafinil—Cough—Doxorubicin—breast cancer	1.85e-05	0.000139	CcSEcCtD
Modafinil—Shock—Epirubicin—breast cancer	1.84e-05	0.000138	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—breast cancer	1.83e-05	0.000138	CcSEcCtD
Modafinil—Diarrhoea—Capecitabine—breast cancer	1.83e-05	0.000138	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—breast cancer	1.83e-05	0.000138	CcSEcCtD
Modafinil—Dizziness—Docetaxel—breast cancer	1.83e-05	0.000137	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—breast cancer	1.83e-05	0.000137	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—breast cancer	1.82e-05	0.000137	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methotrexate—breast cancer	1.82e-05	0.000137	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—breast cancer	1.81e-05	0.000136	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—breast cancer	1.81e-05	0.000136	CcSEcCtD
Modafinil—Insomnia—Methotrexate—breast cancer	1.81e-05	0.000136	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—breast cancer	1.79e-05	0.000135	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.79e-05	0.000134	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—breast cancer	1.78e-05	0.000134	CcSEcCtD
Modafinil—Anorexia—Epirubicin—breast cancer	1.78e-05	0.000134	CcSEcCtD
Modafinil—Dyspnoea—Methotrexate—breast cancer	1.78e-05	0.000134	CcSEcCtD
Modafinil—Somnolence—Methotrexate—breast cancer	1.77e-05	0.000133	CcSEcCtD
Modafinil—Dizziness—Capecitabine—breast cancer	1.77e-05	0.000133	CcSEcCtD
Modafinil—Methadone—ABCB1—breast cancer	1.77e-05	0.00694	CrCbGaD
Modafinil—Dry mouth—Doxorubicin—breast cancer	1.76e-05	0.000132	CcSEcCtD
Modafinil—Vomiting—Docetaxel—breast cancer	1.76e-05	0.000132	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—breast cancer	1.76e-05	0.000132	CcSEcCtD
Modafinil—Rash—Docetaxel—breast cancer	1.75e-05	0.000131	CcSEcCtD
Modafinil—Hypotension—Epirubicin—breast cancer	1.75e-05	0.000131	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—breast cancer	1.74e-05	0.000131	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—breast cancer	1.74e-05	0.000131	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—breast cancer	1.74e-05	0.00013	CcSEcCtD
Modafinil—Headache—Docetaxel—breast cancer	1.73e-05	0.00013	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—breast cancer	1.73e-05	0.00013	CcSEcCtD
Modafinil—Oedema—Doxorubicin—breast cancer	1.73e-05	0.00013	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—breast cancer	1.72e-05	0.000129	CcSEcCtD
Modafinil—Fatigue—Methotrexate—breast cancer	1.72e-05	0.000129	CcSEcCtD
Modafinil—Infection—Doxorubicin—breast cancer	1.72e-05	0.000129	CcSEcCtD
Modafinil—Pain—Methotrexate—breast cancer	1.71e-05	0.000128	CcSEcCtD
Modafinil—Vomiting—Capecitabine—breast cancer	1.7e-05	0.000128	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—breast cancer	1.7e-05	0.000128	CcSEcCtD
Modafinil—Shock—Doxorubicin—breast cancer	1.7e-05	0.000128	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—breast cancer	1.7e-05	0.000127	CcSEcCtD
Modafinil—Rash—Capecitabine—breast cancer	1.69e-05	0.000127	CcSEcCtD
Modafinil—Insomnia—Epirubicin—breast cancer	1.69e-05	0.000127	CcSEcCtD
Modafinil—Dermatitis—Capecitabine—breast cancer	1.69e-05	0.000127	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—breast cancer	1.69e-05	0.000127	CcSEcCtD
Modafinil—Headache—Capecitabine—breast cancer	1.68e-05	0.000126	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—breast cancer	1.68e-05	0.000126	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—breast cancer	1.68e-05	0.000126	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—breast cancer	1.67e-05	0.000125	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—breast cancer	1.67e-05	0.000125	CcSEcCtD
Modafinil—Somnolence—Epirubicin—breast cancer	1.66e-05	0.000125	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—breast cancer	1.65e-05	0.000124	CcSEcCtD
Modafinil—Nausea—Docetaxel—breast cancer	1.65e-05	0.000123	CcSEcCtD
Modafinil—Feeling abnormal—Methotrexate—breast cancer	1.64e-05	0.000123	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—breast cancer	1.64e-05	0.000123	CcSEcCtD
Modafinil—Gastrointestinal pain—Methotrexate—breast cancer	1.63e-05	0.000123	CcSEcCtD
Modafinil—Decreased appetite—Epirubicin—breast cancer	1.62e-05	0.000122	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—breast cancer	1.62e-05	0.000121	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—breast cancer	1.61e-05	0.000121	CcSEcCtD
Modafinil—Fatigue—Epirubicin—breast cancer	1.61e-05	0.000121	CcSEcCtD
Modafinil—Constipation—Epirubicin—breast cancer	1.6e-05	0.00012	CcSEcCtD
Modafinil—Pain—Epirubicin—breast cancer	1.6e-05	0.00012	CcSEcCtD
Modafinil—Nausea—Capecitabine—breast cancer	1.59e-05	0.00012	CcSEcCtD
Modafinil—Urticaria—Methotrexate—breast cancer	1.59e-05	0.000119	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—breast cancer	1.58e-05	0.000118	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—breast cancer	1.58e-05	0.000118	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.57e-05	0.000118	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—breast cancer	1.56e-05	0.000117	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—breast cancer	1.55e-05	0.000117	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—breast cancer	1.54e-05	0.000116	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—breast cancer	1.54e-05	0.000116	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—breast cancer	1.54e-05	0.000115	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—breast cancer	1.53e-05	0.000115	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—breast cancer	1.52e-05	0.000114	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—breast cancer	1.5e-05	0.000113	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—breast cancer	1.49e-05	0.000112	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—breast cancer	1.49e-05	0.000112	CcSEcCtD
Modafinil—Urticaria—Epirubicin—breast cancer	1.48e-05	0.000111	CcSEcCtD
Modafinil—Pain—Doxorubicin—breast cancer	1.48e-05	0.000111	CcSEcCtD
Modafinil—Constipation—Doxorubicin—breast cancer	1.48e-05	0.000111	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—breast cancer	1.48e-05	0.000111	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—breast cancer	1.48e-05	0.000111	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—breast cancer	1.47e-05	0.00011	CcSEcCtD
Modafinil—Asthenia—Methotrexate—breast cancer	1.43e-05	0.000108	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—breast cancer	1.42e-05	0.000107	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—breast cancer	1.41e-05	0.000106	CcSEcCtD
Modafinil—Pruritus—Methotrexate—breast cancer	1.41e-05	0.000106	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—breast cancer	1.38e-05	0.000103	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—breast cancer	1.37e-05	0.000103	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—breast cancer	1.37e-05	0.000103	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—breast cancer	1.37e-05	0.000103	CcSEcCtD
Modafinil—Diarrhoea—Methotrexate—breast cancer	1.37e-05	0.000103	CcSEcCtD
Modafinil—Asthenia—Epirubicin—breast cancer	1.34e-05	0.000101	CcSEcCtD
Modafinil—Pruritus—Epirubicin—breast cancer	1.32e-05	9.92e-05	CcSEcCtD
Modafinil—Dizziness—Methotrexate—breast cancer	1.32e-05	9.91e-05	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—breast cancer	1.28e-05	9.59e-05	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—breast cancer	1.27e-05	9.56e-05	CcSEcCtD
Modafinil—Vomiting—Methotrexate—breast cancer	1.27e-05	9.53e-05	CcSEcCtD
Modafinil—Rash—Methotrexate—breast cancer	1.26e-05	9.45e-05	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—breast cancer	1.26e-05	9.44e-05	CcSEcCtD
Modafinil—Headache—Methotrexate—breast cancer	1.25e-05	9.39e-05	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—breast cancer	1.24e-05	9.31e-05	CcSEcCtD
Modafinil—Dizziness—Epirubicin—breast cancer	1.24e-05	9.27e-05	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—breast cancer	1.22e-05	9.18e-05	CcSEcCtD
Modafinil—Vomiting—Epirubicin—breast cancer	1.19e-05	8.92e-05	CcSEcCtD
Modafinil—Nausea—Methotrexate—breast cancer	1.19e-05	8.9e-05	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—breast cancer	1.18e-05	8.88e-05	CcSEcCtD
Modafinil—Rash—Epirubicin—breast cancer	1.18e-05	8.84e-05	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—breast cancer	1.18e-05	8.83e-05	CcSEcCtD
Modafinil—Headache—Epirubicin—breast cancer	1.17e-05	8.78e-05	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—breast cancer	1.14e-05	8.58e-05	CcSEcCtD
Modafinil—Nausea—Epirubicin—breast cancer	1.11e-05	8.33e-05	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—breast cancer	1.1e-05	8.25e-05	CcSEcCtD
Modafinil—Rash—Doxorubicin—breast cancer	1.09e-05	8.18e-05	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—breast cancer	1.09e-05	8.17e-05	CcSEcCtD
Modafinil—Headache—Doxorubicin—breast cancer	1.08e-05	8.13e-05	CcSEcCtD
Modafinil—Nausea—Doxorubicin—breast cancer	1.03e-05	7.71e-05	CcSEcCtD
Modafinil—CYP2C9—Metabolism—BCHE—breast cancer	3.14e-06	6.01e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ERCC2—breast cancer	3.13e-06	5.99e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—breast cancer	3.12e-06	5.97e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A5—breast cancer	3.1e-06	5.93e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—IDH1—breast cancer	3.1e-06	5.93e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA1—breast cancer	3.1e-06	5.93e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.09e-06	5.91e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—breast cancer	3.09e-06	5.91e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGFR1—breast cancer	3.08e-06	5.9e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—breast cancer	3.08e-06	5.89e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ACHE—breast cancer	3.08e-06	5.89e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAT2—breast cancer	3.07e-06	5.87e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ERCC2—breast cancer	3.06e-06	5.86e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—breast cancer	3.04e-06	5.81e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NCOA1—breast cancer	3.01e-06	5.75e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A1—breast cancer	3e-06	5.73e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NQO1—breast cancer	3e-06	5.73e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—breast cancer	2.96e-06	5.67e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—STK11—breast cancer	2.96e-06	5.67e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP19A1—breast cancer	2.96e-06	5.67e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—breast cancer	2.95e-06	5.63e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—breast cancer	2.94e-06	5.62e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.93e-06	5.61e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP3A4—breast cancer	2.92e-06	5.59e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP17A1—breast cancer	2.92e-06	5.58e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.91e-06	5.56e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—breast cancer	2.9e-06	5.55e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ENO1—breast cancer	2.89e-06	5.52e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS1—breast cancer	2.89e-06	5.52e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—breast cancer	2.88e-06	5.51e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.88e-06	5.5e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1B1—breast cancer	2.87e-06	5.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.84e-06	5.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2D6—breast cancer	2.83e-06	5.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—breast cancer	2.83e-06	5.41e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.82e-06	5.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FN1—breast cancer	2.8e-06	5.35e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.78e-06	5.32e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOA2—breast cancer	2.78e-06	5.32e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NFKBIA—breast cancer	2.76e-06	5.28e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—COMT—breast cancer	2.75e-06	5.27e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—breast cancer	2.74e-06	5.24e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NCOA1—breast cancer	2.74e-06	5.24e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH1—breast cancer	2.74e-06	5.23e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—breast cancer	2.72e-06	5.2e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—breast cancer	2.7e-06	5.17e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—STK11—breast cancer	2.7e-06	5.17e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP19A1—breast cancer	2.7e-06	5.17e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ITPR1—breast cancer	2.7e-06	5.16e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FASN—breast cancer	2.7e-06	5.16e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MED12—breast cancer	2.69e-06	5.14e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—DPYD—breast cancer	2.69e-06	5.14e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCHE—breast cancer	2.68e-06	5.13e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—breast cancer	2.68e-06	5.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—breast cancer	2.68e-06	5.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KIT—breast cancer	2.68e-06	5.12e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—breast cancer	2.66e-06	5.08e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A5—breast cancer	2.65e-06	5.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDOA—breast cancer	2.65e-06	5.06e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGF—breast cancer	2.64e-06	5.06e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—breast cancer	2.6e-06	4.96e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA3—breast cancer	2.57e-06	4.92e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—breast cancer	2.56e-06	4.9e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NQO1—breast cancer	2.56e-06	4.9e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A1—breast cancer	2.56e-06	4.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A2—breast cancer	2.55e-06	4.88e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TYMS—breast cancer	2.55e-06	4.87e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.54e-06	4.85e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NCOR1—breast cancer	2.52e-06	4.82e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—breast cancer	2.52e-06	4.82e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.52e-06	4.82e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BRAF—breast cancer	2.51e-06	4.81e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—COMT—breast cancer	2.51e-06	4.8e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.51e-06	4.8e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CPT1A—breast cancer	2.5e-06	4.78e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCG2—breast cancer	2.5e-06	4.78e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTR—breast cancer	2.5e-06	4.78e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—breast cancer	2.5e-06	4.78e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP3A4—breast cancer	2.5e-06	4.78e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.48e-06	4.75e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—breast cancer	2.48e-06	4.73e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—breast cancer	2.47e-06	4.71e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ITPR1—breast cancer	2.46e-06	4.7e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1B1—breast cancer	2.46e-06	4.7e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HPGDS—breast cancer	2.45e-06	4.69e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—breast cancer	2.45e-06	4.68e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT2—breast cancer	2.45e-06	4.68e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—breast cancer	2.44e-06	4.66e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HBA1—breast cancer	2.44e-06	4.66e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—breast cancer	2.42e-06	4.63e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—breast cancer	2.41e-06	4.61e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.41e-06	4.6e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—breast cancer	2.39e-06	4.57e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ACHE—breast cancer	2.38e-06	4.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—breast cancer	2.38e-06	4.55e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ERCC2—breast cancer	2.37e-06	4.53e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—breast cancer	2.37e-06	4.52e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	2.35e-06	4.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOA1—breast cancer	2.34e-06	4.48e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	2.33e-06	4.45e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	2.33e-06	4.45e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TYMS—breast cancer	2.32e-06	4.44e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP19A1—breast cancer	2.31e-06	4.41e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—STK11—breast cancer	2.31e-06	4.41e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—breast cancer	2.3e-06	4.4e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NCOR1—breast cancer	2.3e-06	4.39e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—breast cancer	2.3e-06	4.39e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.3e-06	4.39e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP17A1—breast cancer	2.25e-06	4.31e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ENO1—breast cancer	2.23e-06	4.26e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS1—breast cancer	2.23e-06	4.26e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—breast cancer	2.23e-06	4.26e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—breast cancer	2.22e-06	4.25e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—breast cancer	2.2e-06	4.21e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2D6—breast cancer	2.19e-06	4.18e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—breast cancer	2.18e-06	4.16e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—breast cancer	2.18e-06	4.16e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.17e-06	4.14e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ERCC2—breast cancer	2.16e-06	4.13e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—breast cancer	2.15e-06	4.11e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—COMT—breast cancer	2.15e-06	4.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA2—breast cancer	2.15e-06	4.1e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—breast cancer	2.14e-06	4.08e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—breast cancer	2.13e-06	4.07e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	2.12e-06	4.05e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MDM2—breast cancer	2.11e-06	4.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—breast cancer	2.11e-06	4.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ITPR1—breast cancer	2.1e-06	4.02e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—breast cancer	2.1e-06	4.02e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAF1—breast cancer	2.1e-06	4.01e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RELA—breast cancer	2.09e-06	4e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FASN—breast cancer	2.08e-06	3.98e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—breast cancer	2.08e-06	3.97e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCHE—breast cancer	2.07e-06	3.96e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—breast cancer	2.05e-06	3.93e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—breast cancer	2.05e-06	3.93e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—breast cancer	2.05e-06	3.92e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	2.05e-06	3.92e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A5—breast cancer	2.05e-06	3.91e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—breast cancer	2.03e-06	3.88e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—breast cancer	2.02e-06	3.87e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—breast cancer	2.01e-06	3.84e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TYMS—breast cancer	1.99e-06	3.8e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NQO1—breast cancer	1.98e-06	3.78e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A1—breast cancer	1.98e-06	3.78e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.97e-06	3.77e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOR1—breast cancer	1.96e-06	3.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—breast cancer	1.96e-06	3.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.96e-06	3.75e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.96e-06	3.75e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.96e-06	3.74e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.92e-06	3.68e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.9e-06	3.64e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—breast cancer	1.9e-06	3.63e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1B1—breast cancer	1.89e-06	3.62e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.89e-06	3.61e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—breast cancer	1.88e-06	3.6e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—breast cancer	1.88e-06	3.59e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—breast cancer	1.88e-06	3.59e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.87e-06	3.58e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—breast cancer	1.87e-06	3.58e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—breast cancer	1.87e-06	3.58e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—breast cancer	1.86e-06	3.56e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.86e-06	3.55e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—breast cancer	1.85e-06	3.55e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ERCC2—breast cancer	1.85e-06	3.53e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—breast cancer	1.84e-06	3.51e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.84e-06	3.51e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUN—breast cancer	1.83e-06	3.5e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.82e-06	3.48e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA1—breast cancer	1.81e-06	3.46e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.79e-06	3.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.78e-06	3.41e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—STK11—breast cancer	1.78e-06	3.41e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP19A1—breast cancer	1.78e-06	3.41e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.78e-06	3.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.77e-06	3.39e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—breast cancer	1.73e-06	3.32e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.73e-06	3.31e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.73e-06	3.3e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—breast cancer	1.71e-06	3.26e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COMT—breast cancer	1.66e-06	3.17e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—breast cancer	1.65e-06	3.15e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—breast cancer	1.64e-06	3.14e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SRC—breast cancer	1.64e-06	3.14e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—breast cancer	1.64e-06	3.13e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—breast cancer	1.63e-06	3.11e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—breast cancer	1.62e-06	3.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ITPR1—breast cancer	1.62e-06	3.1e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—breast cancer	1.6e-06	3.06e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—breast cancer	1.6e-06	3.06e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.6e-06	3.06e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.58e-06	3.03e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—breast cancer	1.56e-06	2.98e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—breast cancer	1.55e-06	2.97e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TYMS—breast cancer	1.53e-06	2.93e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.53e-06	2.92e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.51e-06	2.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOR1—breast cancer	1.51e-06	2.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—breast cancer	1.51e-06	2.9e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.51e-06	2.89e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—breast cancer	1.5e-06	2.87e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—breast cancer	1.48e-06	2.83e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—breast cancer	1.47e-06	2.81e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.47e-06	2.81e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—breast cancer	1.46e-06	2.79e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—breast cancer	1.45e-06	2.77e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.44e-06	2.75e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—breast cancer	1.44e-06	2.75e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—breast cancer	1.43e-06	2.74e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ERCC2—breast cancer	1.42e-06	2.72e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—breast cancer	1.42e-06	2.72e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—breast cancer	1.42e-06	2.71e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.36e-06	2.6e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—breast cancer	1.34e-06	2.56e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—breast cancer	1.31e-06	2.5e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—breast cancer	1.29e-06	2.48e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—breast cancer	1.28e-06	2.45e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—breast cancer	1.26e-06	2.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.25e-06	2.39e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—breast cancer	1.24e-06	2.37e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—breast cancer	1.23e-06	2.36e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—breast cancer	1.21e-06	2.31e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—breast cancer	1.21e-06	2.31e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—breast cancer	1.16e-06	2.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.16e-06	2.21e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—breast cancer	1.13e-06	2.16e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—breast cancer	1.13e-06	2.16e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—breast cancer	1.12e-06	2.15e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—breast cancer	1.12e-06	2.14e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—breast cancer	1.11e-06	2.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—breast cancer	1.11e-06	2.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.02e-06	1.95e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—breast cancer	9.89e-07	1.89e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—breast cancer	9.76e-07	1.87e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—breast cancer	9.65e-07	1.85e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—breast cancer	9.45e-07	1.81e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—breast cancer	9.34e-07	1.79e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—breast cancer	9.23e-07	1.77e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—breast cancer	8.74e-07	1.67e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—breast cancer	8.62e-07	1.65e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—breast cancer	8.54e-07	1.63e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—breast cancer	7.97e-07	1.52e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—breast cancer	7.45e-07	1.42e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—breast cancer	7.14e-07	1.37e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—breast cancer	6.81e-07	1.3e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—breast cancer	6.51e-07	1.24e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—breast cancer	5.56e-07	1.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—breast cancer	5.25e-07	1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—breast cancer	4.29e-07	8.21e-06	CbGpPWpGaD
